Noah Medical develops the Galaxy System™, a robotic platform that utilizes TiLT+ Technology™ for real-time navigation and guidance in lung procedures, enhancing diagnostic yield by addressing CT-to-body divergence. This system features a single-use bronchoscope to reduce cross-contamination risks and improve procedural efficiency in interventional pulmonology.
Funding
$286.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.


PVSVFounders
Product
Problem
Bronchoscopic diagnosis of peripheral lung lesions often suffers from low biopsy yield due to inaccurate lesion localization, limited intra‑procedural imaging, and the need for complex instrument reprocessing, leading to delayed cancer detection and higher procedural costs.
Solution
Noah Medical’s Galaxy System integrates robotic navigation with embedded imaging technologies—Digital Tomosynthesis and Augmented Fluoroscopy—to provide real‑time, three‑dimensional lesion visualization and precise tool‑in‑lesion confirmation during bronchoscopy. The system’s single‑use scope eliminates cleaning and reprocessing, reducing turnover time and infection risk. Adaptive workflow software streamlines the procedure, allowing clinicians to update lesion location intra‑operatively and adjust tool trajectories with confidence. Clinical studies report diagnostic yields up to 96.7% and accuracy around 95%, while cost‑benefit analyses demonstrate favorable OR and suite economics. Together, these capabilities aim to increase early lung cancer detection and improve procedural efficiency.
Target Audience
Primary customers are interventional pulmonologists and thoracic surgery centers performing robotic bronchoscopy for peripheral lung lesion diagnosis, as well as hospital systems seeking to improve procedural efficiency and diagnostic yield.
Features
- Integrated Digital Tomosynthesis creates 3D reconstructions from intra‑operative C‑arm images for precise lesion mapping
- Augmented Fluoroscopy overlays target markers on live fluoroscopy, enabling micro‑adjustments for true tool‑in‑lesion confirmation
- Robotic navigation platform delivers sub‑millimeter precision in instrument positioning
- Single‑use disposable bronchoscope removes reprocessing steps, reducing turnaround time and contamination risk
- Adaptive workflow software consolidates imaging, navigation, and reporting into a unified interface
- Compact system footprint fits existing bronchoscopy suites and supports rapid room turnover